MRSA (Methicillin Resistant Staphylococcus Aureus) News and Research

RSS

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

Swissmedic, the Swiss agency for therapeutic products, has approved Zevtera (ceftobiprole medocaril) for the treatment of complicated skin and soft tissue infections, including diabetic foot infections which have not spread to the bone.

13 Nov 2008

U.S. 'super bugs' invading several Colombian cities

Two clones of highly antibiotic-resistant organism strains, which previously had only been identified in the United States, are now causing serious sickness and death in several Colombian cities including the capital Bogota, say researchers at The University of Texas Medical School at Houston.

12 Nov 2008

Superbugs on the rise in Canadian hospitals

Although infection control has been substantially ramped up in Canadian hospitals since the SARS crisis of 2003, the number of resistant bacterial infections post-SARS have multiplied even faster, a new Queen's University study shows.

8 Nov 2008

Accelr8 announces study results with BACcel diagnostic system for broad resistance in gram-negative pathogens

Accelr8 Technology Corporation announced study results today that were presented at the joint sessions of the 48 th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC, www.icaac.org) and the Infectious Diseases Society of America (IDSA, www.idsociety.org), October 25-29 in Washington, DC.

7 Nov 2008

Scientists step closer to finding a defense against superbugs

A discovery from the Oklahoma Medical Research Foundation has put scientists are one step closer to finding a defense against dangerous antibiotic-resistant bacteria, sometimes called "superbugs."

4 Nov 2008

How to avoid superbugs

At any one time, up to 30% of perfectly healthy people carry the bacterium Staphylococcus aureus, which lives in the human nose.

4 Nov 2008

Researchers downplay value of mandatory universal nasal screening of patients for MRSA

Three Virginia Commonwealth University epidemiologists are downplaying the value of mandatory universal nasal screening of patients for MRSA, arguing that proven, hospital-wide infection control practices can prevent more of the potentially fatal infections.

23 Oct 2008

More hospital cleaners the answer to superbugs

Ultra-sensitive nanoprobes help tackle MRSA

This week Nature Nanotechnology journal (October 12th) reveals how scientists from the London Centre for Nanotechnology (LCN) at University College London are using a novel nanomechanical approach to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as methicillin-resistant Staphylococcus aureus (MRSA).

12 Oct 2008

The healing power of honey for wounds

Since ancient times honey has been valued for its health benefits and is even mentioned in the Bible and it has had a prominent a role in the customs and diets of many cultures for centuries.

12 Oct 2008

Bayer's new oral anticoagulant Xarelto (Rivaroxaban) gets European licence

A new drug launched today could help in the fight against what experts and campaigners are calling a 'major patient safety issue' - the prevention of hospital-acquired DVT (deep vein thrombosis).

2 Oct 2008

Science backs old fashioned belief in the healing powers of honey

Research by Canadian scientists lends support to the old fashioned belief in the healing powers of honey.

25 Sep 2008

Pfizer to withdraw global marketing applications for Dalbavancin to conduct a new trial

Pfizer Inc today announced it will globally withdraw all dalbavancin marketing applications for the treatment of complicated skin and skin structure infections in adults, including the U.S. new drug application (NDA) and the European marketing authorization application (MAA).

9 Sep 2008

Bacteria's sticky glue is clue to vaccine says scientist

Sticky glue secreted by the bacterium Staphylococcus aureus could be the clue scientists have been searching for to make an effective vaccine against MRSA, medical researchers heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

9 Sep 2008

Light activated treatments could solve MRSA problems after surgery

Killer dyes that can wipe out bacteria could help solve the superbug problems faced by surgical patients, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

9 Sep 2008

New CDC push to teach parents how to protect children from MRSA

The Centers for Disease Control and Prevention (CDC) today launched a national campaign to teach parents how to keep their children safe from skin infections caused by the potentially dangerous bacteria Methicillin-resistant Staphylococcus aureus (MRSA).

8 Sep 2008

Light-activated drug used to tackle MRSA

New treatment using a light-activated drug could revolutionise the fight against hospital "superbug", MRSA (otherwise known as Meticillin resistant staphylococcus aureus) it was revealed at the British Pharmaceutical Conference (BPC) in Manchester.

7 Sep 2008

MRSA breast infections controllable in nursing mothers, researchers find

Many nursing mothers who have been hospitalized for breast abscesses are afflicted with the "superbug" methicillin-resistant Staphylococcus aureus, or MRSA, but according to new research by UT Southwestern Medical Center physicians, conservative treatment can deal with the problem.

3 Sep 2008

Nature inspires new highly specific drugs and organic products

The best place to seek novel compounds for pharmaceutical drugs, alternative energy sources, and a host of industrial applications, is within natural systems that have evolved over millions of years.

2 Sep 2008